I believe it is important to assess the change from a patient impact point of view. Any small design change can have rather large implications to sterility, packaging, or even biocompatibility. These types of changes should be heavily considered and observed from those standpoints and generally, there are SMEs that will assess the change from those standpoints if it is applicable.